GSA CAPITAL PARTNERS LLP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 37 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$232
-60.6%
88,923
-46.0%
0.02%
-66.1%
Q2 2023$589
+6.3%
164,596
+257.5%
0.06%
-14.5%
Q4 2022$554
-98.9%
46,039
+134.2%
0.07%
+666.7%
Q3 2020$51,00019,6590.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders